HolmesC.J., LewisS.L., KubeyW.Y.Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with high or low incidence of peritonitis.Am J Kidney Dis1990; 15: 258–64.
2.
LewisS.L., NorrisP.J., HolmesC.J.Phenotypic characterization of monocytes and macrophages from CAPD patients.ASAIO Trans1990; 36: M575–7.
3.
FoxL., TzamaloukasA.H., MurataG.H.Metabolic differences between persistent and routine peritonitis in continuous ambulatory peritoneal dialysis (CAPD).Adv Perit Dial1992; 8: 346–50.
4.
TzamaloukasA.H.Inadequacy of dialysis and infectious complications of CAPD: Diagnosis, management and prevention.Am Kidney Fund Nephrol Lett1991; 8: 29–36.
TzamaloukasA.H., YuanZ.Y., BalaskasE.Continuous ambulatory peritoneal dialysis in diabetics. An update.Adv Perit Dial1992; 8: 185–91.
7.
LindbladA.S., NovakJ.W., NolphK.D.Continuous ambulatory peritoneal dialysis in the USA. Final report of the National CAPD Registry 1981–1988. Dordrecht: Kluwer, 1989.
8.
TranaeusA., HeimburgerO., LindholmB.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): Diagnostic findings, therapeutic outcome and complications.Perit Dial Int1989; 9: 179–90.
9.
TzamaloukasA.H., RogersK., FergusonB.Management of diabetics on CAPD with subcutaneous insulin.Adv CAPD1988; 4: 126–32.
10.
RottembourgJ., IssadB., AllouacheM.Clinical aspects of continuous ambulatory and continuous cyclic peritoneal dialysis in diabetic patients.Perit Dial Int1989; 9: 289–94.